Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 219 entries
Sorted by: Best Match Show Resources per page
Psychological dynamics and self-perceptions of vasectomy candidates.

Perceptual and motor skills

Hamersma RJ, Anderegg T, Miller C, Rudolph B.
PMID: 1178345
Percept Mot Skills. 1975 Jun;40(3):1004-6. doi: 10.2466/pms.1975.40.3.1004.

Growing concern with population control has focused attention on various methods of contraception including vasectomy. Psychological research on this topic is scant, however. In this study, 9 vasectomy candidates who were undergoing the operation were compared to 9 husbands...

Cite
Hamersma RJ, Anderegg T, Miller C, et al. Psychological dynamics and self-perceptions of vasectomy candidates. Percept Mot Skills. 1975;40(3):1004-6doi: 10.2466/pms.1975.40.3.1004.
Hamersma, R. J., Anderegg, T., Miller, C., & Rudolph, B. (1975). Psychological dynamics and self-perceptions of vasectomy candidates. Perceptual and motor skills, 40(3), 1004-6. https://doi.org/10.2466/pms.1975.40.3.1004
Hamersma, R J, et al. "Psychological dynamics and self-perceptions of vasectomy candidates." Perceptual and motor skills vol. 40,3 (1975): 1004-6. doi: https://doi.org/10.2466/pms.1975.40.3.1004
Hamersma RJ, Anderegg T, Miller C, Rudolph B. Psychological dynamics and self-perceptions of vasectomy candidates. Percept Mot Skills. 1975 Jun;40(3):1004-6. doi: 10.2466/pms.1975.40.3.1004. PMID: 1178345.
Copy Download .nbib Format: NLM
[Experiences with surgical therapy of Budd-Chiari syndrome].

Zentralblatt fur Chirurgie

Rückert JC, Wolff H, Ridwelski K, Rudolph B, Staffa G, Romaniuk P.
PMID: 1642051
Zentralbl Chir. 1992;117(5):282-93.

The obstruction of the hepatic venous outflow tract with or without involvement of the inferior vena cava results in the Budd-Chiari syndrome (BCS). With its very heterogenous etiology and variable epidemiology the rare disease either takes a chronic or...

Cite
Rückert JC, Wolff H, Ridwelski K, et al. Erfahrungen mit der chirurgischen Therapie des Budd-Chiari-Syndroms. [Experiences with surgical therapy of Budd-Chiari syndrome]. Zentralbl Chir. 1992;117(5):282-93
Rückert, J. C., Wolff, H., Ridwelski, K., Rudolph, B., Staffa, G., & Romaniuk, P. (1992). Erfahrungen mit der chirurgischen Therapie des Budd-Chiari-Syndroms. [Experiences with surgical therapy of Budd-Chiari syndrome]. Zentralblatt fur Chirurgie, 117(5), 282-93.
Rückert, J C, et al. "Erfahrungen mit der chirurgischen Therapie des Budd-Chiari-Syndroms." [Experiences with surgical therapy of Budd-Chiari syndrome]. Zentralblatt fur Chirurgie vol. 117,5 (1992): 282-93.
Rückert JC, Wolff H, Ridwelski K, Rudolph B, Staffa G, Romaniuk P. Erfahrungen mit der chirurgischen Therapie des Budd-Chiari-Syndroms. [Experiences with surgical therapy of Budd-Chiari syndrome]. Zentralbl Chir. 1992;117(5):282-93. German. PMID: 1642051.
Copy Download .nbib Format: NLM
[The accuracy of the imaging procedures (sonography, MRT, CT, angio-CT,nuclear medicine) in characterizing liver tumors].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Lüning M, Koch M, Abet L, Wolff H, Wenig B, Buchali K, Schöpke W, Schneider T, Mühler A, Rudolph B.
PMID: 1850156
Rofo. 1991 Apr;154(4):398-406. doi: 10.1055/s-2008-1033157.

In a prospective study, an attempt was made to determine the specificity of various imaging methods for defining tumours of the liver rather than their ability to demonstrate them. It was based on 130 patients with histologically confirmed lesions...

Cite
Lüning M, Koch M, Abet L, et al. Treffsicherheit bildgebender Verfahren (Sonographie, MRT, CT, Angio-CT, Nuklearmedizin) bei der Charakterisierung von Lebertumoren. [The accuracy of the imaging procedures (sonography, MRT, CT, angio-CT,nuclear medicine) in characterizing liver tumors]. Rofo. 1991;154(4):398-406doi: 10.1055/s-2008-1033157.
Lüning, M., Koch, M., Abet, L., Wolff, H., Wenig, B., Buchali, K., Schöpke, W., Schneider, T., Mühler, A., & Rudolph, B. (1991). Treffsicherheit bildgebender Verfahren (Sonographie, MRT, CT, Angio-CT, Nuklearmedizin) bei der Charakterisierung von Lebertumoren. [The accuracy of the imaging procedures (sonography, MRT, CT, angio-CT,nuclear medicine) in characterizing liver tumors]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 154(4), 398-406. https://doi.org/10.1055/s-2008-1033157
Lüning, M, et al. "Treffsicherheit bildgebender Verfahren (Sonographie, MRT, CT, Angio-CT, Nuklearmedizin) bei der Charakterisierung von Lebertumoren." [The accuracy of the imaging procedures (sonography, MRT, CT, angio-CT,nuclear medicine) in characterizing liver tumors]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin vol. 154,4 (1991): 398-406. doi: https://doi.org/10.1055/s-2008-1033157
Lüning M, Koch M, Abet L, Wolff H, Wenig B, Buchali K, Schöpke W, Schneider T, Mühler A, Rudolph B. Treffsicherheit bildgebender Verfahren (Sonographie, MRT, CT, Angio-CT, Nuklearmedizin) bei der Charakterisierung von Lebertumoren. [The accuracy of the imaging procedures (sonography, MRT, CT, angio-CT,nuclear medicine) in characterizing liver tumors]. Rofo. 1991 Apr;154(4):398-406. doi: 10.1055/s-2008-1033157. German. PMID: 1850156.
Copy Download .nbib Format: NLM
Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application.

Arzneimittel-Forschung

Woodcock BG, Merz PG, Rietbrock S, Rudolph B, Pfleiderer S.
PMID: 8369004
Arzneimittelforschung. 1993 Jul;43(7):734-6.

The linearity of the relationship between dose and plasma concentration of nifedipine has been investigated in healthy male and female subjects under steady state conditions following application of a fatty alcohol matrix slow release nifedipine (Aprical long, CAS 21829-25-4)...

Cite
Woodcock BG, Merz PG, Rietbrock S, et al. Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application. Arzneimittelforschung. 1993;43(7):734-6
Woodcock, B. G., Merz, P. G., Rietbrock, S., Rudolph, B., & Pfleiderer, S. (1993). Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application. Arzneimittel-Forschung, 43(7), 734-6.
Woodcock, B G, et al. "Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application." Arzneimittel-Forschung vol. 43,7 (1993): 734-6.
Woodcock BG, Merz PG, Rietbrock S, Rudolph B, Pfleiderer S. Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application. Arzneimittelforschung. 1993 Jul;43(7):734-6. PMID: 8369004.
Copy Download .nbib Format: NLM
Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?.

Clinical chemistry

Jung K, Elgeti U, Lein M, Brux B, Sinha P, Rudolph B, Hauptmann S, Schnorr D, Loening SA.
PMID: 10620572
Clin Chem. 2000 Jan;46(1):55-62.

BACKGROUND: The aim of this study was to compare the diagnostic utility of a new assay that measures all forms of prostate-specific antigen complexed (cPSA) to serum proteins except alpha(2)-macroglobulin with the assay of free PSA (fPSA) and the...

Cite
Jung K, Elgeti U, Lein M, et al. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?. Clin Chem. 2000;46(1):55-62
Jung, K., Elgeti, U., Lein, M., Brux, B., Sinha, P., Rudolph, B., Hauptmann, S., Schnorr, D., & Loening, S. A. (2000). Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?. Clinical chemistry, 46(1), 55-62.
Jung, K, et al. "Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?." Clinical chemistry vol. 46,1 (2000): 55-62.
Jung K, Elgeti U, Lein M, Brux B, Sinha P, Rudolph B, Hauptmann S, Schnorr D, Loening SA. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?. Clin Chem. 2000 Jan;46(1):55-62. PMID: 10620572.
Copy Download .nbib Format: NLM
Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation.

Oncogene

Rudolph B, Hueber AO, Evan GI.
PMID: 11313860
Oncogene. 2001 Mar 08;20(10):1164-75. doi: 10.1038/sj.onc.1204196.

To investigate Mad1 function in vivo, transgenic mice were generated that express a Mad1 transgene in T lineage cells under the control of the proximal lck promoter. Thymus size in lck-Mad1 transgenic mice is drastically reduced although representation of...

Cite
Rudolph B, Hueber AO, Evan GI. Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. Oncogene. 2001;20(10):1164-75doi: 10.1038/sj.onc.1204196.
Rudolph, B., Hueber, A. O., & Evan, G. I. (2001). Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. Oncogene, 20(10), 1164-75. https://doi.org/10.1038/sj.onc.1204196
Rudolph, B, et al. "Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation." Oncogene vol. 20,10 (2001): 1164-75. doi: https://doi.org/10.1038/sj.onc.1204196
Rudolph B, Hueber AO, Evan GI. Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. Oncogene. 2001 Mar 08;20(10):1164-75. doi: 10.1038/sj.onc.1204196. PMID: 11313860.
Copy Download .nbib Format: NLM
De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Waiser J, Budde K, Rudolph B, Ortner MA, Neumayer HH.
PMID: 10469868
Am J Kidney Dis. 1999 Sep;34(3):556-9. doi: 10.1016/s0272-6386(99)70085-5.

After renal transplantation, hemolytic uremic syndrome (HUS) may occur as recurrent disease or de novo. Here, we describe the de novo occurrence of HUS immediately after the onset of primary cytomegalovirus (CMV) disease in two renal allograft recipients. Patient...

Cite
Waiser J, Budde K, Rudolph B, et al. De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection. Am J Kidney Dis. 1999;34(3):556-9doi: 10.1016/s0272-6386(99)70085-5.
Waiser, J., Budde, K., Rudolph, B., Ortner, M. A., & Neumayer, H. H. (1999). De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection. American journal of kidney diseases : the official journal of the National Kidney Foundation, 34(3), 556-9. https://doi.org/10.1016/s0272-6386(99)70085-5
Waiser, J, et al. "De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 34,3 (1999): 556-9. doi: https://doi.org/10.1016/s0272-6386(99)70085-5
Waiser J, Budde K, Rudolph B, Ortner MA, Neumayer HH. De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection. Am J Kidney Dis. 1999 Sep;34(3):556-9. doi: 10.1016/s0272-6386(99)70085-5. PMID: 10469868.
Copy Download .nbib Format: NLM
Action of Myc in vivo - proliferation and apoptosis.

Current opinion in genetics & development

Pelengaris S, Rudolph B, Littlewood T.
PMID: 10679391
Curr Opin Genet Dev. 2000 Feb;10(1):100-5. doi: 10.1016/s0959-437x(99)00046-5.

The protein products of many dominant oncogenes are capable of inducing both cell proliferation and apoptosis. Recent experiments employing transgenic mice that express an ectopically regulatable myc gene or protein have begun to elucidate the role of the balance...

Cite
Pelengaris S, Rudolph B, Littlewood T. Action of Myc in vivo - proliferation and apoptosis. Curr Opin Genet Dev. 2000;10(1):100-5doi: 10.1016/s0959-437x(99)00046-5.
Pelengaris, S., Rudolph, B., & Littlewood, T. (2000). Action of Myc in vivo - proliferation and apoptosis. Current opinion in genetics & development, 10(1), 100-5. https://doi.org/10.1016/s0959-437x(99)00046-5
Pelengaris, S, et al. "Action of Myc in vivo - proliferation and apoptosis." Current opinion in genetics & development vol. 10,1 (2000): 100-5. doi: https://doi.org/10.1016/s0959-437x(99)00046-5
Pelengaris S, Rudolph B, Littlewood T. Action of Myc in vivo - proliferation and apoptosis. Curr Opin Genet Dev. 2000 Feb;10(1):100-5. doi: 10.1016/s0959-437x(99)00046-5. PMID: 10679391.
Copy Download .nbib Format: NLM
Legal problems in tissue transplantation.

Transplantation proceedings

Bredehorn T, Rudolph B.
PMID: 12270429
Transplant Proc. 2002 Sep;34(6):2345-6. doi: 10.1016/s0041-1345(02)03266-9.

No abstract available.

Cite
Bredehorn T, Rudolph B. Legal problems in tissue transplantation. Transplant Proc. 2002;34(6):2345-6doi: 10.1016/s0041-1345(02)03266-9.
Bredehorn, T., & Rudolph, B. (2002). Legal problems in tissue transplantation. Transplantation proceedings, 34(6), 2345-6. https://doi.org/10.1016/s0041-1345(02)03266-9
Bredehorn, T, and Rudolph, B. "Legal problems in tissue transplantation." Transplantation proceedings vol. 34,6 (2002): 2345-6. doi: https://doi.org/10.1016/s0041-1345(02)03266-9
Bredehorn T, Rudolph B. Legal problems in tissue transplantation. Transplant Proc. 2002 Sep;34(6):2345-6. doi: 10.1016/s0041-1345(02)03266-9. PMID: 12270429.
Copy Download .nbib Format: NLM
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.

European urology

Lichtinghagen R, Musholt PB, Lein M, Römer A, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA, Jung K.
PMID: 12361907
Eur Urol. 2002 Oct;42(4):398-406. doi: 10.1016/s0302-2838(02)00324-x.

OBJECTIVE: The aim of this study was to assess the behavior of the matrix metalloproteinases (MMPs) 2 and 9 and the tissue inhibitor of metalloproteinases 1 (TIMP-1) in human prostate cancer.METHODS: mRNA and protein expression patterns of MMP-2, MMP-9,...

Cite
Lichtinghagen R, Musholt PB, Lein M, et al. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol. 2002;42(4):398-406doi: 10.1016/s0302-2838(02)00324-x.
Lichtinghagen, R., Musholt, P. B., Lein, M., Römer, A., Rudolph, B., Kristiansen, G., Hauptmann, S., Schnorr, D., Loening, S. A., & Jung, K. (2002). Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. European urology, 42(4), 398-406. https://doi.org/10.1016/s0302-2838(02)00324-x
Lichtinghagen, Ralf, et al. "Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue." European urology vol. 42,4 (2002): 398-406. doi: https://doi.org/10.1016/s0302-2838(02)00324-x
Lichtinghagen R, Musholt PB, Lein M, Römer A, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA, Jung K. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol. 2002 Oct;42(4):398-406. doi: 10.1016/s0302-2838(02)00324-x. PMID: 12361907.
Copy Download .nbib Format: NLM
Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study.

Gastrointestinal endoscopy

Pohl H, Rösch T, Tanczos BT, Rudolph B, Schlüns K, Baumgart DC.
PMID: 19560762
Gastrointest Endosc. 2009 Nov;70(5):933-41. doi: 10.1016/j.gie.2009.04.043. Epub 2009 Jun 27.

BACKGROUND: Endocytoscopy (EC) is a novel technique that allows magnified live inspection of the intestinal mucosa.OBJECTIVE: To evaluate EC for the detection of key pathological findings in patients with celiac sprue.DESIGN: A total of 166 EC recordings were prospectively...

Cite
Pohl H, Rösch T, Tanczos BT, et al. Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study. Gastrointest Endosc. 2009;70(5):933-41doi: 10.1016/j.gie.2009.04.043.
Pohl, H., Rösch, T., Tanczos, B. T., Rudolph, B., Schlüns, K., & Baumgart, D. C. (2009). Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study. Gastrointestinal endoscopy, 70(5), 933-41. https://doi.org/10.1016/j.gie.2009.04.043
Pohl, Heiko, et al. "Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study." Gastrointestinal endoscopy vol. 70,5 (2009): 933-41. doi: https://doi.org/10.1016/j.gie.2009.04.043
Pohl H, Rösch T, Tanczos BT, Rudolph B, Schlüns K, Baumgart DC. Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study. Gastrointest Endosc. 2009 Nov;70(5):933-41. doi: 10.1016/j.gie.2009.04.043. Epub 2009 Jun 27. PMID: 19560762.
Copy Download .nbib Format: NLM
Formation of a chronic pain syndrome due to mesh shrinkage after laparoscopic intraperitoneal onlay mesh (IPOM).

Surgical laparoscopy, endoscopy & percutaneous techniques

Klein F, Ospina C, Rudolph B, Wüstefeld J, Denecke T, Neuhaus P, Schmidt SC.
PMID: 23047409
Surg Laparosc Endosc Percutan Tech. 2012 Oct;22(5):e288-90. doi: 10.1097/SLE.0b013e31825efc3c.

The case of a 58-year-old male patient who developed a chronic pain syndrome after laparoscopic intraperitoneal onlay mesh for treatment of a large symptomatic umbilical hernia combined with rectus diastasis is reported. Twelve months after an uncomplicated initial surgery,...

Cite
Klein F, Ospina C, Rudolph B, et al. Formation of a chronic pain syndrome due to mesh shrinkage after laparoscopic intraperitoneal onlay mesh (IPOM). Surg Laparosc Endosc Percutan Tech. 2012;22(5):e288-90doi: 10.1097/SLE.0b013e31825efc3c.
Klein, F., Ospina, C., Rudolph, B., Wüstefeld, J., Denecke, T., Neuhaus, P., & Schmidt, S. C. (2012). Formation of a chronic pain syndrome due to mesh shrinkage after laparoscopic intraperitoneal onlay mesh (IPOM). Surgical laparoscopy, endoscopy & percutaneous techniques, 22(5), e288-90. https://doi.org/10.1097/SLE.0b013e31825efc3c
Klein, Fritz, et al. "Formation of a chronic pain syndrome due to mesh shrinkage after laparoscopic intraperitoneal onlay mesh (IPOM)." Surgical laparoscopy, endoscopy & percutaneous techniques vol. 22,5 (2012): e288-90. doi: https://doi.org/10.1097/SLE.0b013e31825efc3c
Klein F, Ospina C, Rudolph B, Wüstefeld J, Denecke T, Neuhaus P, Schmidt SC. Formation of a chronic pain syndrome due to mesh shrinkage after laparoscopic intraperitoneal onlay mesh (IPOM). Surg Laparosc Endosc Percutan Tech. 2012 Oct;22(5):e288-90. doi: 10.1097/SLE.0b013e31825efc3c. PMID: 23047409.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 219 entries